🇺🇸
United States · US · US:64764-253_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857
OSENI
Orange BookUNIISPLATC A10BH
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerTakeda Pharmaceuticals America, Inc.
CountryUS (United States)
ATC codeA10BH
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc11647642530330 TABLET, FILM COATED in 1 BOTTLE (64764-253-03)
- ndc11647642530490 TABLET, FILM COATED in 1 BOTTLE (64764-253-04)
- ndc116476425305500 TABLET, FILM COATED in 1 BOTTLE (64764-253-05)
Annotations
UNII (FDA Substance ID)
EEN99869SC
ALOGLIPTIN BENZOATE
RxCUI 1368000
Orange Book
N022426
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "EEN99869SC",
"rxcui": "1368000",
"inchikey": "KEJICOXJTRHYAK-XFULWGLBSA-N",
"display_name": "ALOGLIPTIN BENZOATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"4c619ed9-fe3e-4158-9938-80c6c3493d55": {
"match": "brand_token",
"title": "OSENI (ALOGLIPTIN AND PIOGLITAZONE) TABLET, FILM COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
"spl_version": "23",
"published_date": "2025-03-24"
}
},
"productid": "64764-253_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857",
"productndc": "64764-253",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "022426",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 25MG BASE;EQ 15MG BASE",
"product_no": "001",
"approval_date": "Jan 25, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 25MG BASE;EQ 30MG BASE",
"product_no": "002",
"approval_date": "Jan 25, 2013"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 25MG BASE;EQ 45MG BASE",
"product_no": "003",
"approval_date": "Jan 25, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "004",
"approval_date": "Jan 25, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 12.5MG BASE;EQ 30MG BASE",
"product_no": "005",
"approval_date": "Jan 25, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "006",
"approval_date": "Jan 25, 2013"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE",
"proprietary_name": "OSENI",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "NDA022426",
"marketing_category": "NDA",
"nonproprietary_name": "alogliptin and pioglitazone",
"start_marketing_date": "20130125",
"active_numerator_strength": "25; 30"
}Related drugs
Other records sharing ATC code A10BH.
- GBAlogliptin 12.5mg / Metformin 1g tabletsJ M McGill Ltd
- GBAlogliptin 12.5mg / Metformin 1g tabletsNiche Pharma Ltd
- GBAlogliptin 12.5mg / Metformin 1g tabletsTakeda UK Ltd
- GBAlogliptin 12.5mg / Metformin 1g tabletsColorama Pharmaceuticals Ltd
- GBAlogliptin 12.5mg / Metformin 1g tabletsEnnogen Healthcare Ltd
- 🇺🇸alogliptin and metformin hydrochlorideA-S Medication Solutions
- 🇺🇸alogliptin and metformin hydrochloridePadagis Israel Pharmaceuticals Ltd
- 🇺🇸alogliptin and metformin hydrochloridePadagis Israel Pharmaceuticals Ltd
Access this data programmatically
Query OSENI and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.